Thu Sep 05 12:48:32 UTC 2024: – ENTOD Pharmaceuticals claimed to have received DCGI approval for its PresVu eye drops, but experts and health officials say the company is presenting false facts.
– The company claimed that PresVu eye drops could reduce the dependency on reading glasses for individuals with Presbyopia, a common age-related vision condition.
– Medical experts say that PresVu is essentially pilocarpine eye drops at a lower concentration, which has been used for decades for glaucoma treatment.
– Dr. Samir Sud of Sharp Sight Eye Hospitals explained that PresVu is essentially pilocarpine in a different concentration, which can have serious complications.
– The company CEO, Nikkhil K Masurkar, emphasized the innovation and affordability of PresVu, while medical experts call it an imperfect and temporary solution for reading problems.

Read More